The recent and long-term insider transactions suggest a bullish sentiment among insiders towards HCW Biologics, despite the company making losses. The high insider ownership indicates that the company is likely run in the interest of all shareholders.
$HCW Biologics(HCWB.US)$Investigator Sponsor of HCW Biologics' Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting
HCW Biologics股票討論區
https://www.moomoo.com/en-us/news/post/7799531/hcw-biologics-says-it-gets-fda-clearance-for-phase---trial-of-cancer-drug-candidate--shares-rise-pre-bell?src=2&futusource=news_stock_stockpagenews&repor
Hi Master @Tupack H Mcsnacks kindly suggest on this stock
暫無評論